| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
Amersham Health R&D AB (Part of GE Healthcare), Malmö, Sweden
Requests for reprints: Jan Ardenkjaer-Larsen, GE Healthcare, The Grove Centre (GC/18), White Lion Road, Amersham, Buckinghamshire HP7 9LL, England. Phone: 792-0210-211; E-mail: jan.henrik.ardenkjaer-larsen{at}ge.com.
The "Warburg effect," an elevation in aerobic glycolysis, may be a fundamental property of cancer cells. For cancer diagnosis and treatment, it would be valuable if elevated glycolytic metabolism could be quantified in an image in animals and humans. The pyruvate molecule is at the metabolic crossroad for energy delivery inside the cell, and with a noninvasive measurement of the relative transformation of pyruvate into lactate and alanine within a biologically relevant time frame (seconds), it may be possible to quantify the glycolytic status of the cells. We have examined the metabolism after i.v. injection of hyperpolarized 13C-pyruvate in rats with implanted P22 tumors. The strongly enhanced nuclear magnetic resonance signal generated by the hyperpolarization techniques allows mapping of pyruvate, lactate, and alanine in a 5 x 5 x 10 mm3 imaging voxel using a 1.5 T magnetic resonance scanner. The magnetic resonance scanning (chemical shift imaging) was initiated 24 seconds after the pyruvate injection and had a duration of 14 seconds. All implanted tumors showed significantly higher lactate content than the normal tissue. The results indicate that noninvasive quantification of localized Warburg effect may be possible. (Cancer Res 2006; 66(22): 10855-60)
This article has been cited by other articles:
|
|
 |
|
  I. Park, P. E. Z. Larson, M. L. Zierhut, S. Hu, R. Bok, T. Ozawa, J. Kurhanewicz, D. B. Vigneron, S. R. VandenBerg, C. D. James, et al. Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors Neuro Oncology, February 1, 2010; 12(2): 133 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. R. Jensen, T. Peitersen, M. Karlsson, R. in 't Zandt, A. Gisselsson, G. Hansson, S. Meier, and M. H. Lerche Tissue-specific Short Chain Fatty Acid Metabolism and Slow Metabolic Recovery after Ischemia from Hyperpolarized NMR in Vivo J. Biol. Chem., December 25, 2009; 284(52): 36077 - 36082. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Bhattacharya, B. D. Ross, and R. Bunger Cardiovascular Applications of Hyperpolarized Contrast Media and Metabolic Tracers Exp Biol Med, December 1, 2009; 234(12): 1395 - 1416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. Gallagher, M. I. Kettunen, D.-E. Hu, P. R. Jensen, R. i. t Zandt, M. Karlsson, A. Gisselsson, S. K. Nelson, T. H. Witney, S. E. Bohndiek, et al. Production of hyperpolarized [1,4-13C2]malate from [1,4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors PNAS, November 24, 2009; 106(47): 19801 - 19806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. R. Vasos, A. Comment, R. Sarkar, P. Ahuja, S. Jannin, J.-P. Ansermet, J. A. Konter, P. Hautle, B. van den Brandt, and G. Bodenhausen Long-lived states to sustain hyperpolarized magnetization PNAS, November 3, 2009; 106(44): 18469 - 18473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Harris, G. Eliyahu, L. Frydman, and H. Degani Kinetics of hyperpolarized 13C1-pyruvate transport and metabolism in living human breast cancer cells PNAS, October 27, 2009; 106(43): 18131 - 18136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Matsumoto, H. Yasui, S. Batra, Y. Kinoshita, M. Bernardo, J. P. Munasinghe, H. Utsumi, R. Choudhuri, N. Devasahayam, S. Subramanian, et al. Simultaneous imaging of tumor oxygenation and microvascular permeability using Overhauser enhanced MRI PNAS, October 20, 2009; 106(42): 17898 - 17903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Schroeder, H. J. Atherton, D. R. Ball, M. A. Cole, L. C. Heather, J. L. Griffin, K. Clarke, G. K. Radda, and D. J. Tyler Real-time assessment of Krebs cycle metabolism using hyperpolarized 13C magnetic resonance spectroscopy FASEB J, August 1, 2009; 23(8): 2529 - 2538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Kelloff, P. Choyke, D. S. Coffey, and for The Prostate Cancer Imaging Working Group Challenges in Clinical Prostate Cancer: Role of Imaging Am. J. Roentgenol., June 1, 2009; 192(6): 1455 - 1470. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Wilson, R. E. Hurd, K. Keshari, M. Van Criekinge, A. P. Chen, S. J. Nelson, D. B. Vigneron, and J. Kurhanewicz From the Cover: Generation of hyperpolarized substrates by secondary labeling with [1,1-13C] acetic anhydride PNAS, April 7, 2009; 106(14): 5503 - 5507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Rizi A new direction for polarized carbon-13 MRI PNAS, April 7, 2009; 106(14): 5453 - 5454. [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Warren, E. Jenista, R. T. Branca, and X. Chen Increasing Hyperpolarized Spin Lifetimes Through True Singlet Eigenstates Science, March 27, 2009; 323(5922): 1711 - 1714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Albers, R. Bok, A. P. Chen, C. H. Cunningham, M. L. Zierhut, V. Y. Zhang, S. J. Kohler, J. Tropp, R. E. Hurd, Y.-F. Yen, et al. Hyperpolarized 13C Lactate, Pyruvate, and Alanine: Noninvasive Biomarkers for Prostate Cancer Detection and Grading Cancer Res., October 15, 2008; 68(20): 8607 - 8615. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Song, K. Shahverdi, D. L. Huso, Y. Wang, J. J. Fox, R. F. Hobbs, B. Gimi, K. L. Gabrielson, M. G. Pomper, B. M. Tsui, et al. An Immunotolerant HER-2/neu Transgenic Mouse Model of Metastatic Breast Cancer Clin. Cancer Res., October 1, 2008; 14(19): 6116 - 6124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. V. Frangioni New Technologies for Human Cancer Imaging J. Clin. Oncol., August 20, 2008; 26(24): 4012 - 4021. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Schroeder, L. E. Cochlin, L. C. Heather, K. Clarke, G. K. Radda, and D. J. Tyler In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance PNAS, August 19, 2008; 105(33): 12051 - 12056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. McFate, A. Mohyeldin, H. Lu, J. Thakar, J. Henriques, N. D. Halim, H. Wu, M. J. Schell, T. M. Tsang, O. Teahan, et al. Pyruvate Dehydrogenase Complex Activity Controls Metabolic and Malignant Phenotype in Cancer Cells J. Biol. Chem., August 15, 2008; 283(33): 22700 - 22708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Pichler, H. F. Wehrl, and M. S. Judenhofer Latest Advances in Molecular Imaging Instrumentation J. Nucl. Med., June 1, 2008; 49(Suppl_2): 5S - 23S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Plathow and W. A. Weber Tumor Cell Metabolism Imaging J. Nucl. Med., June 1, 2008; 49(Suppl_2): 43S - 63S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Cai and X. Chen Multimodality Molecular Imaging of Tumor Angiogenesis J. Nucl. Med., June 1, 2008; 49(Suppl_2): 113S - 128S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kurhanewicz, R. Bok, S. J. Nelson, and D. B. Vigneron Current and Potential Applications of Clinical 13C MR Spectroscopy J. Nucl. Med., March 1, 2008; 49(3): 341 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Brindle Detecting Early Tumor Responses to Therapy Using Magnetic Resonance Imaging and Spectroscopy Am. Assoc. Cancer Res. Educ. Book, April 14, 2007; 2007(1): 85 - 90. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
